Yoshiaki Kanemoto Selected Research

Yoshiaki Kanemoto Research Topics

7	Neoplasms (Cancer) 01/2023 - 01/2021
4	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2021
2	Thiamine Deficiency 09/2021 - 03/2020
2	Rectal Neoplasms (Rectal Cancer) 06/2021 - 12/2019
2	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 01/2019
2	Cholangitis 03/2019 - 11/2015
1	Chronic Disease (Chronic Diseases) 08/2023
1	Osteoporosis 08/2023
1	Hepatocellular Carcinoma (Hepatoma) 10/2022
1	Internal Hernia 08/2022
1	Folic Acid Deficiency (Folic Acid Deficiencies) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Pancytopenia 01/2022
1	Edema (Dropsy) 12/2021
1	Dysphonia (Spastic Dysphonia) 12/2021
1	Hyperammonemia 06/2021
1	Adenoma (Adenomas) 06/2021
1	Diverticulitis 01/2021
1	Carcinogenesis 01/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2020
1	Cognitive Dysfunction 03/2020
1	Colitis 01/2020
1	Lymphatic Metastasis 03/2019
1	Fatigue 03/2019
1	Stomach Neoplasms (Stomach Cancer) 03/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Cholangiocarcinoma 11/2015

4	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 01/2021
3	ChromatinIBA 01/2023 - 01/2022
3	AndrogensIBA 01/2023 - 01/2021
2	Enhancer RNAsIBA 01/2023 - 01/2021
2	LigandsIBA 01/2023 - 01/2022
2	Thiamine (Aneurin)FDA Link 09/2021 - 03/2020
1	CalciumIBA 08/2023
1	Estrogens (Estrogen)FDA Link 08/2023
1	Estrogen ReceptorsIBA 08/2023
1	Vitamin D FDA LinkGeneric 08/2023
1	Selective Estrogen Receptor Modulators (SERM)IBA 08/2023
1	bicalutamide (Casodex)FDA LinkGeneric 01/2023
1	Androgen Receptor AntagonistsIBA 01/2023
1	hydroxide ionIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022
1	Testosterone CongenersIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 12/2021
1	afliberceptIBA 12/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2021
1	NivolumabIBA 12/2021
1	Panitumumab (Vectibix)FDA Link 12/2021
1	A-factor (Streptomyces)IBA 12/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Staphylococcal Protein A (Protein A)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 03/2020
1	Serum AlbuminIBA 03/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2019
1	Methotrexate (Mexate)FDA LinkGeneric 03/2019

7	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
2	Therapeutics 01/2023 - 06/2021
2	Gastrectomy 01/2022 - 03/2019
1	Castration 01/2023
1	Laparotomy 08/2022
1	Aftercare (After-Treatment) 01/2022
1	Chemoradiotherapy 06/2021
1	Appendectomy 06/2021
1	Conservative Treatment 01/2021
1	Ileostomy 01/2020
1	Neoadjuvant Therapy 12/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2019
1	Stents 11/2015